Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
0.00
-0.5950 (-0.92%)
Apr 29, 2026, 9:37 AM EDT - Market open
Company Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States.
The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.
The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force.
Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
Establishment Labs Holdings Inc.
| Country | United States |
| Founded | 2004 |
| IPO Date | Jul 19, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,004 |
| CEO | Fillipo Caldini |
Contact Details
Address: 11401 century oaks terrace, suite 400 Austin, Texas 78758 United States | |
| Phone | 800 924 5072 |
| Website | establishmentlabs.com |
Stock Details
| Ticker Symbol | ESTA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001688757 |
| CUSIP Number | G31249108 |
| ISIN Number | VGG312491084 |
| Employer ID | 98-1436377 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Fillipo Peter Caldini | Chief Executive Officer and Director |
| Juan Jose Chacon Quiros | Founder and Executive Director |
| S. Ross Mansbach | General Counsel, Chief Compliance Officer and Chief Human Resources Officer |
| Rajbir Singh Denhoy | Senior Vice President of Global Strategy |
| Cassandra E. Harris | Senior Vice President and Chief Financial Officer |
| Roberto de Mezerville | Chief Technology Officer |
| Ivan Bilic | Senior Vice President of Commercial Operations - OUS |
| Jeff Ehrhardt | Senior Vice President and GM of North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 24, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 10, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 10, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 23, 2026 | 144 | Filing |
| Feb 27, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 27, 2026 | 10-K | Annual Report |
| Feb 24, 2026 | 8-K | Current Report |
| Feb 19, 2026 | SCHEDULE 13G/A | Filing |
| Feb 13, 2026 | SCHEDULE 13G/A | Filing |
| Feb 13, 2026 | SCHEDULE 13G/A | Filing |